Cart
sales@molnova.com
Cilansetron
CAS No. 120635-74-7
Cilansetron( —— )
Catalog No. M34208 CAS No. 120635-74-7
Cilansetron is an effective and selective 5-HT3 receptor antagonist that can be used for related diseases caused by colitis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 459 | In Stock |
|
| 10MG | 657 | In Stock |
|
| 25MG | 1026 | In Stock |
|
| 50MG | 1386 | In Stock |
|
| 100MG | 1832 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCilansetron
-
NoteResearch use only, not for human use.
-
Brief DescriptionCilansetron is an effective and selective 5-HT3 receptor antagonist that can be used for related diseases caused by colitis.
-
DescriptionCilansetron is an effective and selective 5-HT3 receptor antagonist that can be used for related diseases caused by colitis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
Target5-HT Receptor
-
Recptor5-HT Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number120635-74-7
-
Formula Weight319.4
-
Molecular FormulaC20H21N3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C=2C=3C=4N(C2CC[C@@H]1CN5C(C)=NC=C5)CCCC4C=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
(Rac)-Norcisapride
Norcisapride is a 5-hydroxytryptamine receptor 3 (5-HT3) and (5-hydroxytryptamine receptor 4 (5-HT4) dual agonist used for the treatment of gastrointestinal disorders, orofacial disorders, and otorhinolaryngologic disorders.
-
p-MPPF
p-MPPF is a selective 5-HT antagonist that dose-dependently antagonizes hypothermia induced by 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and can be used to study neurological diseases.
-
SB 216641 hydrochlor...
SB 216641 hydrochloride (SB-216641A) is a selective 5-HT1B/D receptor antagonist with anxiolytic properties that antagonizes the vasoconstrictor response mediated by sumatriptan.
